In article number 1705436, Shaobing Zhou, Zi Chen, and co-workers develop an acid-active tumor-targeting nanoplatform with self-reported drug-release capability. This platform has unique features, such as a long blood circulation through shielding of the cationic charges of trans-activating transcriptional activator (TAT), an enhanced cellular internalization by regenerating the original TAT in acidic tumor tissue, and a self-reported drug release via the Förster resonance energy transfer (FRET) signal triggered by the intracellular reductant.
http://ift.tt/2DbsZgE
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.